NEWS/EVENTS What’s New in the CVF Portfolio? Sep 16, 2025 Dualitas Launches With $65 Million Series A to Advance Novel Bispecific Antibody Pipeline in Immune and Inflammatory DiseaseMay 13, 2025Stylus Medicine Launches to Develop Precision, In Vivo Genetic Medicines and Unlock the Full Potential of CAR-T Therapy 2025 2024 Nov 12, 2024Hyku Biosciences Appoints John Gustofson to its Board of DirectorsOct 30, 2024Chugai Venture Fund Announces the First Investment Agreement with Leal Therapeutics 2023 Jun 27, 2023Chugai Establishes Corporate Venture Capital to Accelerate Innovation Opportunities with Drug Discovery Start-ups
